• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,583.22 -1,690.23
( -2.25%)
Global Indices
Nasdaq
45,986.51 -463.99
(-1.00%)
Dow Jones
6,496.71 -116.19
(-1.76%)
Hang Seng
53,412.46 -191.19
(-0.36%)
Nikkei 225
9,975.43 -131.41
(-1.30%)
Forex
USD-INR
93.86 0.07
(0.08%)
EUR-INR
108.76 0.06
(0.06%)
GBP-INR
125.66 0.01
(0.01%)
JPY-INR
0.59 0.00
(-0.13%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5329749
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
238.13
53.15
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

algoquant fintech ltd
NMDC records 16% YoY increase in iron ore production for February'26
Mar 02,2026
Iron ore sales jumped 15.6% YoY to 4.60 MT in February 2026 as against 3.98 MT in February 2025.

For the period up to February 2026, iron ore production and sales were 47.79 MT (up 18% YoY) and 44.34 MT (up 10.3% YoY), respectively.

NMDC is engaged in exploration and production of iron ore along with diamond production and sale of sponge iron and generation and sale of wind power.

The company’s consolidated net profit declined 7.9% to Rs 1,747.01 crore on a 15.9% rise in revenue from operations to Rs 7,610.79 crore in Q3 FY26 over Q3 FY25.

The scrip shed 0.73% to close at Rs 81.20 on the BSE.